Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Environ Pollut ; 285: 117485, 2021 Sep 15.
Article in English | MEDLINE | ID: covidwho-1252841


The consumption of disposable face masks increases greatly because of the outbreak of the COVID-19 pandemic. Inappropriate disposal of wasted face masks has already caused the pollution of the environment. As made from plastic nonwoven fabrics, disposable face masks could be a potential source of microplastics for the environment. In this study, we evaluated the ability of new and used disposable face masks of different types to release microplastics into the water. The microplastic release capacity of the used masks increased significantly from 183.00 ± 78.42 particles/piece for the new masks to 1246.62 ± 403.50 particles/piece. Most microplastics released from the face masks were medium size transparent polypropylene fibers originated from the nonwoven fabrics. The abrasion and aging during the using of face masks enhanced the releasing of microplastics since the increasing of medium size and blue microplastics. The face masks could also accumulate airborne microplastics during use. Our results indicated that used disposable masks without effective disposal could be a critical source of microplastics in the environment. The efficient allocation of mask resources and the proper disposal of wasted masks are not only beneficial to pandemic control but also to environmental safety.

COVID-19 , Microplastics , Humans , Masks , Pandemics , Plastics , SARS-CoV-2
Medicine (Baltimore) ; 99(47): e23225, 2020 Nov 20.
Article in English | MEDLINE | ID: covidwho-939606


BACKGROUND: The outbreak of a novel coronavirus (2019-nCoV)-infected pneumonia is currently ongoing all over the world. The treatment scheme is generally isolation treatment and symptomatic support treatment. While the majority of patients recover from this disease through methods above, COVID-19 Infection severely affect the physical and mental health of rehabilitation patients, as well as their living quality. Thus, meditative movement is needed to improve outcome of COVID-19 patients in recovery period. METHODS: We will conduct systematic searches to identify all relevant studies without any language limitation from the following electronic databases from inception to October 2020: Medline, Ovid, PubMed, Embase, Cochrane Library, Google Scholar, China National Knowledge Infrastructure (CNKI), Chinese Scientific Journals Database (VIP), Chinese Biomedical Database, Chinese Biomedical Literature Service System and Wan fang Database. At the same time, we will search the following Clinical trial registries to identify records of on-going or completed but not yet published trials, including WHO International Clinical Trials Registry Platform (ICTRP), Trials Register of Promoting Health Interventions (TRoPHI) and Chinese Clinical Trial Registry (ChiCTR). No limits will be placed on language. The article will study the effect of meditative movement on the quality of life of convalescent patients. The main outcome will be the effect of meditative movement on the quality of life of patients in recovery period. The secondary results will select accompanying symptoms (including myalgia, cough, sputum, runny nose, pharyngalgia, anhelation, chest distress, nausea, vomiting, anorexia, diarrhea), disappearance rate, negative COVID-19 results rate on 2 consecutive occasions (not on the same day), the quality of life improved, CT image improvement, average hospitalization time, occurrence rate of common type to severe form, clinical cure rate, and mortality. Data collection and management 3 authors will independently carry out data from eligible studies in a pretested and standardized Microsoft Excel sheet, with reciprocal validation of data extraction results. Data analysis and quantitative data synthesis will be performed using RevMan software (V.5.3). RESULTS: The findings of the study will provide new and relatively high-quality evidence in meditative movement treatment for COVID-19. CONCLUSION: The conclusion of systematic review will provide evidence to judge whether meditative movement is an effective intervention for patient with COVID-19 in recovery period. PROSPERO REGISTRATION NUMBER: CRD42020210256.

Betacoronavirus , Coronavirus Infections/rehabilitation , Exercise Movement Techniques/methods , Meditation/methods , Pneumonia, Viral/rehabilitation , Quality of Life , COVID-19 , Coronavirus Infections/psychology , Female , Humans , Male , Meta-Analysis as Topic , Pandemics , Pneumonia, Viral/psychology , Research Design , SARS-CoV-2 , Systematic Reviews as Topic , Treatment Outcome